Long-term workforce participation patterns following head and neck cancer

J Cancer Surviv. 2015 Mar;9(1):30-9. doi: 10.1007/s11764-014-0382-2. Epub 2014 Jul 25.

Abstract

Purpose: This analysis describes the long-term workforce participation patterns of individuals diagnosed with head and neck cancer (HNC).

Methods: Survivors of HNC (ICD10 C00-C14, C32) diagnosed at least 8 months previously were identified from the National Cancer Registry Ireland and sent a survey including questions about working arrangements before and since diagnosis. Descriptive statistics and multivariate logistic regression were used to examine the factors that influence workforce participation at 0, 1 and 5 years after diagnosis.

Results: Two hundred sixty-four individuals employed at the time of diagnosis responded to the survey, an average 6 years post-diagnosis. Seventy-seven percent took time off work after diagnosis, with a mean work absence of 9 months (range 0-65 months). Fifty-two percent of participants reduced their working hours (mean reduction 15 h/week). The odds of workforce participation following HNC were increased by not being eligible for free medical care (OR 2.61, 95% CI 1.15-5.94), having lip, mouth or salivary gland cancer (compared to cancer of the pharynx or cancer of the larynx, OR 2.79, 1.20-6.46), being self-employed (OR 2.01, 1.07-3.80), having private health insurance (OR 2.06, 1.11-3.85) and not receiving chemotherapy (OR 2.82, 1.31-6.06). After 5 years, only the effect of medical card remained (i.e., medical insurance) (OR 4.03, 1.69-9.62).

Conclusions: Workforce participation patterns after HNC are complex and are influenced by cancer, treatment and employment factors.

Implications for cancer survivors: Patients should be informed of the potential impacts of HNC on workforce participation, and clinicians, policy makers and employers should be aware of these potential longer-term effects and related variables.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Employment / statistics & numerical data*
  • Female
  • Head and Neck Neoplasms / epidemiology*
  • Head and Neck Neoplasms / mortality
  • Humans
  • Male
  • Middle Aged
  • Quality of Life
  • Survivors